31 reports

  • EYE CARE IN THE US - CATEGORY ANALYSIS
  • Eye Health Supplement Growth Boosting Eye Care Awareness

The US has one of the most liberal approaches to OTC distribution in the world.

  • Ophthalmic Solution
  • OTC
  • United States
  • Demand

The 2019-2024 Outlook for Eye Care Treatment in the United States ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Ophthalmic Solution
  • OTC
  • United States
  • Demand

The 2019-2024 Outlook for Optical Goods and Eye Care Products in the United States ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Ophthalmic Solution
  • OTC
  • United States
  • Demand
  • EYE CARE IN THE US - CATEGORY ANALYSIS
  • EYE CARE IN THE US - CATEGORY ANALYSIS

Due to this, allergy eye care has maintained a stronger growth rate than standard eye care in recent years.

  • Ophthalmic Solution
  • United States
  • Demand
  • Bayer AG
  • Prestige Brands Holdings, Inc.
  • 10.11 DOMPE
  • SUN PHARMA'S DES PORTFOLIO ASSESSMENT, 2018

DES IS ONE OF THE MOST COMMON OCULAR DISEASES, AND EYE CARE SPECIALISTS TYPICALLY ENCOUNTER PEOPLE WITH THIS OCULAR CONDITION ON A DAILY BASIS.

  • Ophthalmic Solution
  • China
  • United States
  • Allergan plc
  • Santen Pharmaceutical Co., Ltd.
  • Focusing on new approvals and product launches Advance its pipeline through increased investment in R&D
  • Implementing inorganic growth strategies Advancing its pipeline through increased investment in R&D

It begins in one eye and spreads to the other.

  • Ophthalmic Solution
  • United States
  • Akorn, Inc.
  • Alcon, Inc.
  • Allergan plc
  • Enhancing its eyecare portfolio Establishing strategic alliances and collaborations
  • KEY M&A

Aazithromycin ##% ophthalmic solution is administered twice daily for two days, followed by once-daily administration for five days.

  • Ophthalmic Solution
  • United States
  • Akorn, Inc.
  • Alcon, Inc.
  • Bausch & Lomb Incorporated
  • Key vendor analysis
  • Vendor landscape

It blocks IL-## receptor signaling and prevents the binding of IL-## alpha and IL-## beta to the IL-## receptor.

  • Ophthalmic Solution
  • United States
  • Akorn, Inc.
  • Alcon, Inc.
  • Allergan plc

For instance, the recent approval of Zerviate (cetirizine) for the treatment of allergic conjunctivitis in 2017 and Humira (adalimumab) and Xiidra (lifitegrast) in 2016 as ophthalmic solutions for the treatment of uveitis and dry eyes are expected to boost the market growth.

  • Ophthalmic Solution
  • OTC
  • Pharmaceutical
  • United States
  • Forecast
  • Sep 20, 2017: Aerie Pharmaceuticals Announces FDA Advisory Committee Meeting for Rhopressa (netarsudil ophthalmic solution) 0.02%
  • Mar 01, 2017: Aerie Pharmaceuticals Announces Resubmission of NDA for Rhopressa (netarsudil ophthalmic solution) 0.02%

Results: (##-##) There were nine yes votes and one no vote.

  • Ophthalmic Solution
  • Ophthalmology
  • Pharmaceutical
  • United States
  • Aerie Pharmaceuticals, Inc.
  • Dry Eye Disease Market: Revenue in USD million, Punctal Plugs, 2016-2024
  • Revenue Breakdown (%), by Business Segments, 2019 (Year Ended March 31, 2019 )

Moreover, the US FDA has also approved lifitegrast ophthalmic solution as a treatment for the signs and symptoms of dry eye disease in adults based on results obtained from one phase ## study, three phase ## studies (OPUS-##, OPUS-##, and OPUS-##), and one long-term ph

  • Eye Disease
  • Ophthalmic Solution
  • Therapy
  • United States
  • Market Size
  • OCT 03, 2013: LUPIN LAUNCHES GENERIC ZYMAXID OPHTHALMIC SOLUTION IN THE US

Food and Drug Administration of a ##% azithromycin ophthalmic solution before the expiration of the patents protecting AzaSite.

  • Eye Disease
  • Ophthalmic Solution
  • United States
  • Litigation And Patent
  • InSite Vision Incorporated
  • JAN 04, 2017: CONTACT LENSES MAKE THE LEAP TO A SUBSCRIPTION MODEL
  • JAN 09, 2017: LENSFERRY S EXPANDS TO INCLUDE ALL CONTACT LENS MODALITIES

With today' s announcement, LensFerry S includes monthly, two-week, and ##-day lenses from multiple manufacturers at eye care professionals' specified prices.

  • Eyewear
  • Ophthalmic Solution
  • United States
  • M&A
  • CooperVision, Inc.
  • MAR 03, 2017: ALCON LAUNCHES NEW DIGITAL VISION CARE MARKETING PORTAL FOR EYE CARE PROFESSIONALS
  • MAR 01, 2018: ALCON US VISION CARE CREATES INNOVATIVE PATIENT AND PRACTICE EXPERIENCE TEAM TO DELIVER CONSULTING EXPERTISE TO PRACTICES

The lenses provide consistent comfort from day ## to day ##.

  • Laboratory
  • Ophthalmic Solution
  • Ophthalmology
  • United States
  • Alcon, Inc.
  • OCT 03, 2013: LUPIN LAUNCHES GENERIC ZYMAXID OPHTHALMIC SOLUTION IN THE US

Food and Drug Administration of a ##% azithromycin ophthalmic solution before the expiration of the patents protecting AzaSite.

  • Eye Disease
  • Ophthalmic Solution
  • United States
  • Litigation And Patent
  • InSite Vision Incorporated
  • 8.2 Merck & Co., Inc.

A phase ##/ ## clinical trial is underway.

  • Ophthalmic Solution
  • United States
  • Alcon, Inc.
  • Allergan plc
  • Bausch & Lomb Incorporated

COMPANY PROFILES Total Companies Profiled: ## (including Divisions/ Subsidiaries - ##) The United States (##) Canada (##) Japan (##) Europe (##) - France (##) - Germany (##) - The United Kingdom (##) - Italy (##) - Spain (##) - Rest of Europe (##) Asia-Pacific (Excluding Japan

  • Ophthalmic Solution
  • OTC
  • APAC
  • United States
  • Company Sales
  • Deal Type
  • Deal Type

Subsequently, Nicox and VISUfarma agreed that Nicox would no longer be responsible for completing development and regulatory approval for AzaSite (azithromycin ophthalmic solution) ##% in Europe.

  • Ophthalmic Solution
  • United States
  • Company
  • M&A
  • NicOx S.A.
  • ALLERGIC CONJUNCTIVITIS - PIPELINE BY OCULAR THERAPEUTIX INC, H2 2018
  • Allergic Conjunctivitis - Drug Profiles

Title: A Randomized Double-Masked Phase ## Clinical Trial of NS## Ophthalmic Solution in Allergic Conjunctivitis Date: Saturday November ##that ##:## p. m.

  • Ophthalmic Solution
  • Therapy
  • United States
  • Product Initiative
  • Aldeyra Therapeutics, Inc.
  • BAUSCH & LOMB ENTERS INTO LICENSING AGREEMENT WITH PARAGON BIOTECK FOR PHENYLEPHRINE
  • Aug 20, 2018: Joseph Gordon Named U.S. President of Bausch + Lomb

Phenylephrine Hydrochloride Ophthalmic Solution, USP ##. ##% and ##% is an alpha-## adrenergic receptor agonist used for dilation of the pupil due to its vasoconstrictor and mydriatic action.

  • Ophthalmic Solution
  • United States
  • Company
  • M&A
  • Bausch & Lomb Incorporated

And some of us respond well to only one of those things, but not both.

  • Clinic
  • Diabetes
  • Ophthalmic Solution
  • United States
  • Joslin Diabetes Center
  • PRT-2761 - DRUG PROFILE
  • EM-100 - DRUG PROFILE

Title: A Randomized Double-Masked Phase ## Clinical Trial of NS## Ophthalmic Solution in Allergic Conjunctivitis Date: Saturday November ##that ##:## p. m.

  • Ophthalmic Solution
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • DEC 13, 2017: COOPERVISION ANNOUNCES NATIONWIDE AVAILABILITY OF EXPANDED PARAMETERS FOR AVAIRA VITALITY TORIC
  • SEP 13, 2017: LENSFERRY NOW OFFERS EHR INTEGRATION; AUTOMATION DRIVES PRACTICE REVENUE

" Eye care professionals now have the ability to significantly enhance their patients' ##-day wearing experience when upgrading to MyDay toric from a ##-day toric hydrogel, " said Dr.

  • Eyewear
  • Ophthalmic Solution
  • United States
  • Product Initiative
  • CooperVision, Inc.
  • APR 27, 2017: NICOX FIRST QUARTER 2017 BUSINESS UPDATE AND CASH POSITION
  • NICOX AMENDS LICENSING AGREEMENT WITH RAPID PATHOGEN SCREENING FOR ADENOPLUS

Subsequently, Nicox and VISUfarma agreed that Nicox would no longer be responsible for completing development and regulatory approval for AzaSite (azithromycin ophthalmic solution) ##% in Europe.

  • Medical Device
  • Ophthalmic Solution
  • United States
  • Company
  • NicOx S.A.
  • BAUSCH & LOMB ENTERS INTO LICENSING AGREEMENT WITH PARAGON BIOTECK FOR PHENYLEPHRINE
  • Jun 20, 2017: Bausch + Lomb Unveils AMD Virtual Experience with State-of-the-Art Technology at Optometry's Meeting

Available to eye care professionals and their patients across the U. S., the Bausch + Lomb ONE by ONE Recycling Program recycles used contact lens materials into post-consumer products.

  • Ophthalmic Solution
  • Ophthalmology
  • United States
  • M&A
  • Bausch & Lomb Incorporated
  • ODOCS EYE CARE LTD PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW

One unit refers to one A - scan.

  • Drug Development
  • Eyewear
  • Ophthalmic Solution
  • United States
  • Company

Bausch + Lomb' s Consumer Healthcare business is one of the fastest growing consumer healthcare businesses in the U. S. ## and the No. ## category growth contributor (##%) in the eye care category.

  • Clinical Trial
  • Eyewear
  • Ophthalmic Solution
  • United States
  • Valeant Pharmaceuticals International, Inc.

ALCON CONDUCTS RESEARCH TO DEVELOP SURGICAL AND EYE CARE PRODUCTS.

  • Laboratory
  • Ophthalmic Solution
  • Ophthalmology
  • United States
  • Alcon, Inc.
  • NATUS MEDICAL ACQUIRES RETCAM OPHTHALMIC IMAGING SYSTEMS FROM CLARITY MEDICAL SYSTEMS FOR USD10.6 MILLION

The Topcon CA-## Corneal Analyzer is one of the newest additions that will assist Franklin Family Eyecare in their goal of providing the best service possible to clients.

  • Eyewear
  • Healthcare
  • Ophthalmic Solution
  • United States
  • Alcon, Inc.
  • Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.
  • 7.3 OTHER SIGNIFICANT DEVELOPMENTS

One unit refers to one microkeratome.

  • Ophthalmic Solution
  • United States
  • Company
  • Market Segment
  • Hoya Corporation